Form 8.3 - UK Commercial Property REIT Limited
May 07, 2024 08:02 ET
|
Rathbones Group PLC
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
XEALTH AND STEL LIFE TEAM UP, CONNECTING PATIENT HEALTH DEVICES AND CARE TEAMS VIA CELLULAR NETWORKS
May 07, 2024 08:02 ET
|
Xealth
SEATTLE and PHILADELPHIA, May 07, 2024 (GLOBE NEWSWIRE) -- Xealth, the leader in enabling digital health at scale, today announced that Stel Life, a leader in health monitoring device connectivity,...
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference
May 07, 2024 08:01 ET
|
Ardelyx, Inc.
WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class...
Zscaler Joins Forces with Google to Offer Unparalleled Zero Trust Data and Threat Protection
May 07, 2024 08:01 ET
|
Zscaler, Inc.
SAN JOSE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, has collaborated with Google on a joint zero trust architecture with Chrome Enterprise....
Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
May 07, 2024 08:01 ET
|
Mainz BioMed NV
Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
Anaqua Unveils PATTSY WAVE Version 8 IP Management Software
May 07, 2024 08:00 ET
|
Anaqua
Anaqua announces the launch of PATTSY WAVE Version 8, the latest release of the patent and trademark management software.
Great Lakes Reports First Quarter 2024 Results
May 07, 2024 08:00 ET
|
Great Lakes Dredge & Dock Corporation
First quarter net income of $21.0 millionFirst quarter adjusted EBITDA of $42.9 millionDredging backlog of $879.4 million at March 31, 2024 HOUSTON, May 07, 2024 (GLOBE NEWSWIRE) -- Great Lakes...
Creyon Bio to Present Clinical Data on Rapid AI-Enabled Engineering of Oligonucleotide-Based Medicines at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
May 07, 2024 08:00 ET
|
Creyon Bio, Inc.
AI-informed drug design enabled approval to dose within one year of project initiation Data highlight use of AI to engineer investigative allele selective antisense oligonucleotide treatment for baby...
Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights
May 07, 2024 08:00 ET
|
Nuvectis Pharma, Inc.
Encouraging preliminary data announced from the NXP800 Phase 1b study in platinum resistant, ARID1a-mutated ovarian cancer, a program granted Fast Track Designation by the US FDAData presented at the...
MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Update
May 07, 2024 08:00 ET
|
MoonLake Immunotherapeutics AG
MoonLake Immunotherapeutics Reports First Quarter 2024 Financial Results and Provides a Business Update Announced positive feedback from both FDA and EMA on the regulatory path for the Phase 3...